|8-KFeb 6, 4:11 PM ET

EDGEWELL PERSONAL CARE Co 8-K

Research Summary

AI-generated summary

Updated

Edgewell Personal Care Announces Sale of Feminine Care to Essity for ~$340M

What Happened Edgewell Personal Care Company announced it completed the previously disclosed sale of its Feminine Care segment to Essity Aktiebolag (publ) on February 2, 2026, pursuant to an Asset Purchase Agreement dated November 12, 2025. At closing Edgewell received approximately $340 million in cash in exchange for the Business; the amount is subject to customary post-closing adjustments for inventory, indebtedness and other items. Edgewell and Essity also entered into a transition services agreement to support the Business following the closing. The company furnished a press release dated February 2, 2026 and filed this Form 8-K on February 6, 2026.

Key Details

  • Buyer: Essity Aktiebolag (publ); Purchase Agreement dated November 12, 2025.
  • Cash proceeds: approximately $340 million at closing, subject to post-closing adjustments (inventory, indebtedness, other items).
  • Closing date: February 2, 2026; transition services agreement executed to support the handover.
  • Financial disclosure: unaudited pro forma condensed consolidated balance sheet as of Sept 30, 2025, and pro forma statements of earnings for fiscal years ended Sept 30, 2025, 2024 and 2023 were furnished (Exhibit 99.2) reflecting the sale.

Why It Matters This transaction removes Edgewell’s Feminine Care segment from its consolidated results and provides near-term cash proceeds (subject to adjustments), which will affect the company’s balance sheet and future revenue/earnings profile. The pro forma financial information included with the filing shows how past results would look without the divested business and helps investors assess post-transaction financials. Investors should review the pro forma statements and the press release for details on the financial impact and any ongoing transition arrangements.